LOTREXON

Welcome to the Brand page for “LOTREXON”, which is offered here for Pharmaceutical preparations and substances that are used alone or in combination with other pharmaceuticals, preparations or substances, and that act on the nervous system; pharmaceutical preparations and substances that that are used alone or in combination with other pharmaceuticals, preparations or substances, and have immunomodulatory activity; pharmaceutical preparations and substances that that are used alone or in combination with other pharmaceuticals, preparations or substances, and have anti-inflammatory activity; pharmaceutical preparations and substances that that are used alone or in combination with other pharmaceuticals, preparations or substances, and have hematopoietic lineage differentiation activity; pharmaceutical preparations and substances that are used alone or in combination with other pharmaceuticals, preparations or substances, and that act on various g protein-coupled receptors; pharmaceutical preparations and substances that are used alone or in combination with other pharmaceuticals, preparations or substances, and that act on non-gpcrs, including toll-like receptors and p receptors; pharmaceutical preparations and substances that are used alone or in combination with other pharmaceuticals, preparations or substances, for the prevention and treatment of gastrointestinal, neurological, immunological, oncological and/or viral diseases and disorders;.

Its status is currently believed to be active. Its class is unavailable. “LOTREXON” is believed to be currently owned by “Cytocom, Inc.”